Who Owns NNNN?
Anbio Biotechnology Class A Ordinary Shares — Institutional Ownership & 13F Holdings
$21.83
+0.32 (+1.46%)
Market Cap
$984.5M
Shares Outstanding
43,891,200
Institutional Holders
3
Total Inst. Value
$495K
% of Float Held
0.2%
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | MARSHALL WACE, LLP | $325K | 43,629 |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | $127K | 17,060 |
| 3 | UBS Group AG | $43K | 5,738 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold NNNN?
As of Q1 2025, 3 institutional investors report holding NNNN (Anbio Biotechnology Class A Ordinary Shares) in their 13F filings.
What percentage of Anbio Biotechnology Class A Ordinary Shares is owned by institutions?
Institutional investors hold approximately 0.2% of Anbio Biotechnology Class A Ordinary Shares's float as reported in SEC 13F filings.
Which hedge fund owns the most NNNN?
The largest institutional holder of NNNN is MARSHALL WACE, LLP with $325K in shares.
Are institutions buying or selling NNNN?
This quarter, 3 institutions opened new positions in NNNN and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.